Hindustan Zinc fertiliser plant likely to be operational by FY27: Chair

Vedanta group firm Hindustan Zinc Ltd (HZL) is likely to begin the operation of its fertilizer manufacturing plant in Rajasthan by the next financial year, company's chairperson Priya Agarwal Hebbar has said.
The company is making its entry into fertilizer production by setting a 0.5 million tonnes (MT) per annum manufacturing plant at Chanderiya in Chittorgarh district of Rajasthan.
"Diversification is central to our growth strategy. Last year, we commissioned a 30 KTPA zinc alloy plant, significantly expanding our value-added products (VAP) portfolio. Including alloys, VAP now contributes 22 per cent to our total business. We are also entering the fertilizer segment with a (diammonium phosphate/nitrogen, phosphorous and potassium) plant expected to become operational by FY27," she said in a recent letter to shareholders.
The plant aims to support farmers' needs through production and sale of DAP fertilizer currently being imported, according to the company's Q4 investor presentation.
These initiatives, she said, will diversify the company's revenue streams and enhance margins.
Hebbar further said that the company's wholly-owned subsidiary Hindmetal Exploration Services is pursuing high-potential exploration blocks across the country for copper, lithium, nickel, cobalt, potash, gold and more. These minerals are critical for electric vehicles, semiconductors and clean technologies.
"We will evolve from a zinc and silver company into a multi-metal, future-enabling enterprise. We are totally aligned with India's critical mineral security vision," the chairperson said.
Hindustan Zinc Ltd reported a 47.3 increase in consolidated net profit at Rs 3,003 crore in the quarter ended March 2025 on the back of higher income.
The company had posted a net profit of Rs 2,038 crore in the year-ago period.
Income of the company during the latest January-March quarter increased to Rs 9,314 crore from Rs 7,822 crore in the year-ago period.
In a statement the company said that it was its "best-ever fourth quarter profit after tax of Rs 3,003 crore, up 47 per cent Y-o-Y".
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

News18

41 minutes ago

• News18

Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP

Last Updated: According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. Influx Healthtech IPO Allotment: The initial public offering of Influx Healthtech has received a whopping 201.35 times subscription, indicating huge interest from investors. Investors are now eagerly awaiting its allotment even its latest GMP shows a strong 22.92% listing gains. The allotment of the Influx Healthtech IPO is expected to be finalised today, Monday, June 23, in the evening. Once the IPO allotment is finalised, investors will start receiving bank debit messages, most probably in the evening. They can also check their allotment status on the websites of the NSE as well as registrar Maashitla Securities Private Limited. The allotment is expected to be finalised in the evening today, Friday, June 20. The allotment status can be checked by following these steps: Step 1: Visit Maashitla Securities' portal — Step 2: Under 'Select Company', choose 'Influx Healthtech Ltd'. Importantly, if the company's name is not visible in the drop-down list, it means the allotment has not been finalised yet. According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Influx Healthtech IPO Listing Date The shares of Influx Healthtech Ltd will be listed on the NSE Emerge on June 25. The Influx Healthtech IPO was open for subscription between June 18 and June 20. It is a book-built issue worth Rs 58.57 crore, comprising a fresh issue of 50 lakh equity shares worth Rs 48 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. On the final day of bidding on Friday, the SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The price of the Influx Healthtech IPO was fixed at Rs 96 apiece. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.

India.com

44 minutes ago

• India.com

Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…

Anil Ambani was already in the news for settling down the debt of his many companies. Now once again it has settled the debt with another company. In a recent exchange filing it stated that it has fully settled a Rs 273-crore loan, including interest, owed by its wholly owned subsidiary JR Toll Road Pvt Ltd (JRTR) to Yes Bank Ltd. It stated, '' A wholly owned subsidiary of the Company (along with the Company as Corporate Guarantor), has entered into an addendum to the Settlement Agreement today with Yes Bank Limited (YBL) for the entire outstanding debt obligation of ~INR 273 crore (including interest) owed by JRTR to YBL, and has duly paid the entire settlement amount.'' Anil Ambani Company Debt Reduction Debt reduction has become a primary focus for Anil Ambani. Reliance Infrastructure: Paid off Rs 3,300 crore of debt in FY 2025, becoming debt-free. Rosa Power Supply Company: Cleared Rs 485 crore of debt, achieving debt-free status. Reliance Power: Settled a loan of Rs 3,872 crore earlier. JR Toll Road Pvt Ltd, a special purpose vehicle established by Reliance Infrastructure, is responsible for the development, operation, and maintenance of a 52-kilometer segment of National Highway 11, connecting Jaipur and Reengus in Rajasthan. The project was executed under the Design-Build-Finance-Operate-Transfer (DBFOT) model, featuring a highway expansion from four to six lanes. Operations commenced in 2013, coinciding with the start of toll collection.

Hindustan Times

an hour ago

• Hindustan Times

Watch with Kannada numerals and Karnataka's iconic crest goes viral: 'Decolonize your mind'

BJP MP Tejasvi Surya criticizes Karnataka's Rs 18,000 crore tunnel road project, calling it unscientific and financially unsound. He questions the project's feasibility, high toll costs, and potential public fund drain, challenging the government's transportation strategy.